Product logins

Find logins to all Clarivate products below.


Interventional Cardiology Devices | Market Insights | Middle East and South Africa | 2021

Although the COVID-19 pandemic will have a negative impact on procedure volumes and market growth in 2020, the MESA IC device market will grow modestly through 2029, driven by the rising prevalence of CAD, expanding penetration of IC procedures, increasing health insurance coverage in some segments, and government initiatives to improve the accessibility and affordability of IC devices.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in the MESA region across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for growth, driven by increasing PCI volumes for complex CAD cases and the adoption of innovative devices and…
Report
Interventional Cardiology Devices – Market Insights – Latin America
The Latin American IC device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption…
Report
Interventional Cardiology Devices – Market Insights – Middle East (Supplemental)
The MESA IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally invasive…
Report
Interventional Cardiology Devices | Market Insights | Latin America (Supplemental) | 2025
The Latin American IC device market has recovered from the COVID-19 pandemic and is reverting to prepandemic growth trends. Increasing patient pool, launch of newer generation devices and…
Report
Interventional Cardiology Devices – Market Insights – Asia Pacific (Supplemental)
The Asia Pacific IC device market is bolstered by a growing CAD patient population, an increasing prevalence of complex lesions, enhanced access to treatment, a rising preference for minimally…